Inhibrx PE Ratio 2020-2022 | INBX
Current and historical p/e ratio for Inhibrx (INBX) from 2020 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Inhibrx PE ratio as of May 27, 2022 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Inhibrx PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2022-05-27 |
13.65 |
|
0.00 |
| 2022-03-31 |
22.28 |
$-2.44 |
0.00 |
| 2021-12-31 |
43.67 |
$-2.15 |
0.00 |
| 2021-09-30 |
33.31 |
$-2.07 |
0.00 |
| 2021-06-30 |
27.52 |
$-2.30 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.533B |
$0.007B |
|
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
|
